Live symbol workspace

VRTX market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Current $428.63

Trend Flat

Sentiment Neutral

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support

$407.20

Resistance

$450.06

Volume & Momentum

Volume

Weak

0.8x avg

Momentum

0%

Weak

Technical Context

Current price

$428.63

RSI context

50

Market Sentiment

50

Neutral

Stock Metrics

Daily Vol

0%

VIX Est

20

Weekly

0%

Asset Intelligence Dossier

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

30%

— 0.0 pts vs previous week

Avg confidence across 3 calls in the last 7 days

What sources say

Bullish 1 article

OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

Neutral 1 article

Vertex Pharmaceuticals (VRTX) Exceeds Market Returns: Some Facts to Consider

Insider Trading

Refreshing insider trades from FinViz…

Technical Observations

Refreshing technical observations from FinViz...

VRTX News Intelligence (5 articles)

AI-curated news influencing VRTX price, sentiment, and trend

Explore All VRTX News with AI Analysis

Economy

2 weeks, 1 day ago

Vertex Pharmaceuticals (VRTX) Exceeds Market Returns: Some Facts to Consider

Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $490.39, moving +2.38% from the previous trading session.

Impact on VRTX: Neutral market sentiment indicated

Financial market analysis indicating neutral sentiment based on current trends. Medium (50%)

View full analysis →

Yahoo Finance 50% confidence

AI & Machine Learning

4 weeks, 1 day ago

OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

Lightspeed is in discussions to lead the funding round, sources say.

Impact on VRTX: The potential launch of this startup, valued at $2B, may positively impact …

Miles Wang, an OpenAI researcher, is in talks to launch an AI drug discovery startup … High (70%)

View full analysis →

TechCrunch 70% confidence

Economy

1 month, 3 weeks ago

2 Reasons to Like VRTX (and 1 Not So Much)

Vertex Pharmaceuticals has been treading water for the past six months, recording a small loss of 1.6% while holding steady …

Impact on VRTX: Neutral market sentiment indicated

Analysis of stock market developments showing neutral sentiment. Medium (50%)

View full analysis →

Yahoo Finance 50% confidence

Economy

1 month, 3 weeks ago

Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Here's Why

In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $451.63, denoting a -1.6% move from the …

Impact on VRTX: The decline in VRTX stock may lead to a sector-wide impact on …

Vertex Pharmaceuticals (VRTX) stock declined 1.6% to $451.63 despite a gaining market, indicating a negative … High (70%)

View full analysis →

Yahoo Finance 70% confidence

Economy

4 months, 2 weeks ago

Where Will Vertex Pharmaceuticals Be in 1 Year?

The biotech's recent dip might be a buying opportunity.

Impact on VRTX: The potential buying opportunity in Vertex Pharmaceuticals may lead to a price …

Vertex Pharmaceuticals' recent dip may present a buying opportunity, but the article lacks specific catalysts … Medium (50%)

View full analysis →

Yahoo Finance 50% confidence